Sweden’s leading business daily Dagens Industri reported on Sigrid’s SEK 44 million financing round, linking the momentum to the global success of Danish obesity and diabetes drugs and to growing interest in new Swedish approaches to metabolic health.
Media Coverage
Danska börsjättens framgångar ger fart till svensk uppstickare
Media: Dagens Industri
Dagens Industri covers Sigrid’s SEK 44 million financing round and how the success of Danish GLP-1 drugs is drawing attention to Swedish innovation.
FinancingSwedish innovationMetabolic health


